Dan Ives, Global Head of Technology Research at Wedbush Securities, talks about how Deepseek has transformed China's role in ...

Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, ...

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on C3ai (AI – Research Report), with a price target of $45.00. The ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange ...

Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reissued by equities research ...

Wedbush analyst Daniel Ives maintained a Buy rating on Pegasystems (PEGA – Research Report) today and set a price target of $125.00. The ...

Palantir (PLTR) plunged 10.08% Wednesday and fell another 2.59% pre-market as investors reacted to potential U.S. defense ...

If the Department of Defense goes through budget cuts as suggested by a leaked memo, Palantir Technologies (PLTR) would have ...

LOS ANGELES--(BUSINESS WIRE)--Wedbush Securities, a leading financial services and investment firm, is proud to announce the launch of fast and efficient services for easy-to-borrow, locates and ...

Analysts at Wedbush issued their FY2029 earnings per share estimates for Aerovate Therapeutics in a research report issued to clients and investors on Monday, February 24th. Wedbush analyst L. Chico ...